Nanoresonator chip-based RNA sensor strategy for detection of circulating tumor cells: Response using PCA3 as a prostate cancer marker

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 8, Issue 6, 2012, Pages 1017-1025

  Sioss, James A ^a   Bhiladvala, Rustom B ^a,b   Pan, Weihua ^c   Li, Mingwei ^a,b   Patrick, Susan ^c   Xin, Ping ^c   Dean, Stacey L ^a   Keating, Christine D ^a   Mayer, Theresa S ^a,b   Clawson, Gary A ^a,c  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b The Pennsylvania State University   (United States)

^c PENN STATE CANCER INSTITUTE   (United States)

Author keywords

CTCs; Nanoresonators; PCA3 (DD3); Prostate cancer

Indexed keywords

ANTISENSE; BOTTOM-UP FABRICATION; CANCER CELL DETECTION; CANCER DETECTION; CIRCULATING TUMOR CELLS; CTCS; DETECTION CAPABILITY; DIRECT DETECTION; FREQUENCY SHIFT; FUNCTIONALIZED NANOWIRE; GOLD NANOPARTICLES; HIGH SPECIFICITY; HYBRID RESONATORS; INTEGRATION SCHEME; NANORESONATORS; PCA3 (DD3); PROSTATE CANCERS; QUANTITATIVE SENSITIVITY; RESONANCE FREQUENCY SHIFT; RNA DETECTION; RNA SENSOR; SINGLE NUCLEOTIDES; TOP-DOWN FABRICATION;

BLOOD; DIAGNOSIS; DISEASES; FREQUENCY SHIFT KEYING; METAL NANOPARTICLES; NANOWIRES;

RNA;

ANTISENSE OLIGONUCLEOTIDE; GOLD NANOPARTICLE; NANORESONATOR; NANOWIRE; RNA; TUMOR MARKER; TUMOR MARKER PCA3; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CIRCULATING TUMOR CELL; CONTROLLED STUDY; HYBRIDIZATION; MICROARRAY ANALYSIS; NANOFABRICATION; NUCLEAR MAGNETIC RESONANCE; PROSTATE CANCER;

ANTIGENS, NEOPLASM; BIOSENSING TECHNIQUES; BLOOD CHEMICAL ANALYSIS; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; HUMANS; MALE; MICRO-ELECTRICAL-MECHANICAL SYSTEMS; NANOTECHNOLOGY; NEOPLASTIC CELLS, CIRCULATING; RNA; TUMOR MARKERS, BIOLOGICAL;

EID: 84864085959     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2011.11.009     Document Type: Article

References (50)

1. Gerges N, Rak J, Jabado N New technologies for the detection of circulating tumour cells. Br Med Bull 2010, 94:49-64.
2. Dawood S, Broglio K, Valero V, Reuben J, Handy B, Islam R, et al. Circulating tumor cells in metastatic breast cancer: from prognostic stratification to modification of the staging system?. Cancer 2008, 113:2422-2430.
3. Dotan E, Cohen SJ, Lapaugh KR, Meropol NJ Circulating tumor cells: evolving evidence and future challenges. Oncologist 2009, 14:1070-1082.
4. Miller MC, Doyle GV, Terstappen LW Significance of circulating tumor cells detected by the cellsearch system in patients with metastatic breast colorectal and prostate cancer. J Oncol 2010, 2010:617421.
5. Smerage JB, Hayes DF The prognostic implications of circulating tumor cells in patients with breast cancer. Cancer Invest 2008, 26:109-114.
6. Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 2004, 351:781-791.
7. Stott SL, Lee RJ, Nagrath S, Yu M, Miyamoto DT, Ulkus L, et al. Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer. Sci Transl Med 2010, 2:25ra23.
8. Helo P, Cronin AM, Danila DC, Wenski S, Gonzalez-Espinoza R, Anand A, et al. Circulating prostate tumor cells detected by reverse transcription-PCR in men with localized or castration-refractory prostate cancer: concordance with CellSearch assay and association with bone metastases and with survival. Clin Chem 2009, 55:765-773.
9. Scher H, Jia X, de Bono JS, Fleisher M, Pienta KJ, Raghaven D, et al. Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer; a reanalysis of IMMC38 trial data. Lancet Oncol 2009, 10:233-239.
10. Wright JL, Lange PH Newer potential biomarkers in prostate cancer. Rev Urol 2007, 9:207-213.
11. Mitas M, Chaudhary U, Marshall D, Gattoni-Celli S Detection of circulating tumor cells in the peripheral blood of patients with androgen-independent, advanced or metastatic prostate cancer. Am J Hematol 2008, 83:87.
12. Kruck S, Gakis G, Stenzl A Circulating and disseminated tumor cells in the management of advanced prostate cancer. Adv Urol 2012, 2012:135281.
13. Jost M, Day JR, Slaughter R, Koreckij TD, Gonzales D, Kinnunen M, et al. Molecular assays for the detection of prostate tumor derived nucleic acids in peripheral blood. Mol Cancer 2010, 9:174-179.
14. Sieuwerts AM, Kraan J, Bolt J, van der Spoel P, Elstrodt F, Schutte M, et al. Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells. J Natl Cancer Inst 2009, 101:61-66.
15. Raimondi C, Gianni W, Cortesi E, Gazzaniga P Cancer stem cells and epithelial-mesencymal transition: revisiting minimal residual disease. Curr Cancer Drug Target 2010, 10:496-508.
16. Armstrong AJ, Marengo MS, Oltean S, Kemeny G, Bitting RL, Turnbull JD, et al. Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers. Mol Cancer Res 2011, 9:997-1007.
17. Fabisiewicz A, Kulik J, Kober P, Brewczynska E, Pienkowski T, Siedlecki J Detection of circulating breast cancer cells in peripheral blood by a two-marker reverse transcriptase-polymerase chain reaction assay. Acta Biochim Polonica 2004, 51:747-755.
18. Mocellin S, Del Fiore P, Guarnieri L, Scalerta R, Foletto M, Chiarion V, et al. Molecular detection of circulating tumor cells is an independent prognostic factor in patients with high-risk cutaneous melanoma. Int J Cancer 2004, 111:741-745.
19. Liotta L, Stetler-Stevenson W Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res 1991, 51:5054s-5059s.
20. Weiss L Metastatic inefficiency. Adv Cancer Res 1990, 54:159-211.
21. Fidler I Metastasis: quantitative analysis of distribution and fate of tumor emboli labeled with 125I-5-iodo-deoxyuridine. J Natl Cancer Inst 1970, 45:773-782.
22. Nakagawa T, Martinez SR, Goto Y, Koyanagi K, Kitago M, Shingai T, et al. Detection of circulating tumor cells in early-stage breast cancer metastasis to axillary lymph nodes. Clin Cancer Res 2007, 13:4105-4110.
23. Fizazi K, Morat L, Chauveinc L, Prapotnich D, De Crevoisier R, Escudier B, et al. High detection rate of circulating tumor cells in blood of patients with prostate cancer using telomerase activity. Ann Oncol 2007, 18:518-521.
24. Schmidt H, DeAngelis G, Eltze E, Gockel I, Semionow A, Brandt B Asynchronous growth of prostate cancer is reflected by circulating tumor cells delivered from distinct, even small foci, harboring loss of heterozygosity of the PTEN gene. Cancer Res 2006, 66:8959-8965.
25. Ali A, Furusato B, Ts'o PO, Lum ZP, Elsamanoudi S, Mohamed A, et al. Assessment of circulating tumor cells (CTCs) in prostate cancer patients with low-volume tumors. Pathol Int 2010, 60:667-672.
26. Su M, Li S, Dravid VP Microcantilever resonance-based DNA detection with nanoparticle probes. Appl Phys Lett 2003, 82:3562-3564.
27. Li M, Bhiladvala RB, Morrow TJ, Sioss JA, Lew KK, Redwing JM, et al. Bottom-up assembly of large-area nanowire resonator arrays. Nat Nanotech 2008, 3:88-92.
28. Li M, Mayer TS, Sioss JA, Keating CD, Bhiladvala RB Template-grown metal nanowires as resonators: performance and characterization of dissipative and elastic properties. Nano Lett 2007, 7:3281-3284.
29. Morrow TJ, Li M, Kim JW, Mayer TS, Keating CD Programmed assembly of DNA-coated nanowire arrays. Science 2009, 323:352.
30. Klecka J, Holubec L, Pesta M, Topolcan O, Hora M, Eret V, et al. Differential display code 3 (DD3/PCA3) in prostate cancer diagnosis. Anticancer Res 2010, 30:665-670.
31. Floriano-Sanchez E, Cardenas-Rodiquez N, Castro-Marin M, Alvarez-Grave P, Lara-Padilla E DD3(PCA3) gene expression in cancer and prostatic hyperplasia. Clin Invest Med 2009, 32:E258.
32. Goodman OBJ, Symanowski JT, Loudyi A, Fink LM, Ward DC, Vogelzang NJ Circulating tumor cells as a predictive biomarker in patients with hormone-sensitive prostate cancer. Clin Genitourin Cancer 2011, 9:31-38.
33. Doyen J, Alix-Panabieres C, Hofman P, Parks SK, Chamorey E, Naman H, et al. Circulating tumor cells in prostate cancer: a potential surrogate marker of survival. Crit Rev Oncol Hematol 2011, Epub Jun 14 (PMID21680196).
34. Durand X, Moutereau S, Xylinas E, de la Taille A Progensa™ PCA3 test for prostate cancer. Expert Rev Mol Diagn 2011, 11:137-144.
35. Arlett JL, Myers EB, Roukes ML Comparative advantages of mechanical biosensors. Nat Nanotech 2011, 6:203-215.
36. Waggoner PS, Tan CP, Craighead HG Mirofluidic integration of nanomechanical resonators for protein analysis in serum. Sensors and Actuators B 2010, 150:550-555.
37. Ekinci KL Electromechanical transducers at the nanoscale: actuation and sensing of motion in nanoelectromechanical systems (NEMS). Small 2005, 1:786-797.
38. Erickson D, Mandal S, Yang AH, Cordovez B Nanobiosensors: optofluidic, electrical and mechanical approaches to biomolecular detection at the nanoscale. Microfluidics Nanofluidics 2008, 4:33-52.
39. Chai D RNA structure and modeling: progress and techniques. Prog Nucleic Acid Res Mol Biol 2008, 82:71-100.
40. Sioss JA, Stoemer RL, Sha MY, Keating CD Silica coated, Au/Ag striped nanowires for bioanalysis. Langmuir 2007, 23:11334-11341.
41. Ramgir NS, Yang YL, Zacharias M Nanowire-based sensors. Small 2010, 6:1705-1722.
42. Bin X, Sargent EH, Kelley SO Nanostructuring of sensors determines the efficiency of biomolecular capture. Anal Chem 2010, 82:5928-5931.
43. Wan Y, Sha J, Chen B, Fang Y, Wang Z, Wang Y Nanodevices based on silicon nanowires. Recent Pat Nanotechnol 2009, 31:1-9.
44. Wang G, Wang Y, Chen L, Choo J Nanomaterial-assisted aptamers for optical sensing. Biosens Bioelectron 2010, 25:1859-1868.
45. Mile E, Jourdan G, Bargatin I, Labarthe S, Marcoux C, Andreucci P, et al. In-plane nanoelectromechanical resonators based on silicone nanowire piezoresistive detection. Nanotechnology 2010, 21:165504.
46. Merkoci A Nanoparticle-based strategies for DNA, protein and cell sensors. Biosens Bioelectron 2010, 26:1164-1177.
47. Jena BK, Ghosh S, Bera R, Dey DS, Das AK, Raj CR Bioanalytical applications of au nanoparticles. Recent Pat Nanotechnol 2010, 4:41-52.
48. Chung YK, Reboud J, Lee KC, Lim HM, Lim PY, Wang KY, et al. An electrical biosensor for the detection of circulating tumor cells. Biosens Bioelectron 2010, 26:2520-2526.
49. Stott SL, Hsu CH, Tsukrov DI, Yu M, Miyamoto DT, Waltman BA, et al. Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. Proc Natl Acad Sci 2010, 107:18392-18397.
50. Yang L, Lang JC, Balasubramanian P, Jatana KR, Schuller D, Agrawal A, et al. Optimization of an enrichment process for circulating tumor cells from the blood of head and neck cancer patients through depletion of normal cells. Biotechnol. Bioeng 2008, 102:521-534.